<DOC>
	<DOCNO>NCT00134979</DOCNO>
	<brief_summary>This study conduct United States . This study design provide efficacy safety data formoterol 10µg twice-a-day ( b.i.d . ) deliver Certihaler patient chronic obstructive pulmonary disease ( COPD ) . This study also design compare efficacy safety therapy formoterol ( Certihaler ) 10µg b.i.d . added tiotropium ( HandiHaler ) 18µg daily ( o.d . ) compare tiotropium ( HandiHaler ) 18µg o.d . monotherapy , compare safety efficacy formoterol 10µg b.i.d . ( Certihaler ) tiotropium 18µg o.d . ( HandiHaler ) .</brief_summary>
	<brief_title>Formoterol Certihaler , Tiotropium HandiHaler Tiotropium HandiHaler Combination With Formoterol Certihaler Patients With Stable Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Cooperative male female diagnosis moderate COPD per Global Initiative Chronic Obstructive Lung Disease ( GOLD ) criteria age onset ≥ 40 year . Current previous smoker smoke history ≥ 10 packyears . Ten packyears define 20 cigarette day 10 year , 10 cigarette day 20 year etc . Prebronchodilator force expiratory volume one second ( FEV1 ) &lt; 70 % patient 's predict normal value ≥ 1.00 L , FEV1/forced vital capacity ( FVC ) &lt; 70 % Visit 2 . A total symptom score patient diary 0 least 4 last 7 day prior Visit 3 Pregnant woman , nurse mother , female childbearing potential , regardless whether sexually active , use reliable contraceptive method ( oral , mechanical , subcutaneous surgical contraception ) . Patients hospitalize acute exacerbation airway diseases month prior Visit 1 screening . Patients respiratory tract infection within 1 month prior Visit 1 . Patients develop respiratory tract infection screen period must discontinue trial , permit reenroll later date ( least 1 month resolution respiratory tract infection ) . Patients concomitant pulmonary disease include history cancer ( ) , pulmonary tuberculosis congenital bronchiectasis . History asthma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>COPD , formoterol ,</keyword>
</DOC>